US Stock MarketDetailed Quotes

ABOS Acumen Pharmaceuticals

Watchlist
  • 1.850
  • +0.050+2.78%
Close Dec 20 16:00 ET
  • 1.900
  • +0.050+2.70%
Post 19:32 ET
111.15MMarket Cap-1.34P/E (TTM)

Acumen Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acumen Pharmaceuticals Q3 2024 Earnings Date

Currency：USDNov 12, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
0
0
0
--
--
--
EPS
-0.37
-0.50
-0.13
Miss Est.
-52.27%
-108.33%
-36.87%
Analyst Rating
Strong Buy

Dec 22, 2024

Acumen Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
Nov 12, 20242024/Q30.000 / 0.000--
Aug 13, 20242024/Q20.000 / 0.000--
May 14, 20242024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Acumen Pharmaceuticals Earnings Reports

  • Acumen Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

    Nov 12 16:33 ET

  • Acumen Pharmaceuticals | 8-K: Acumen Pharmaceuticals Reports Third Quarter 2024 Financial Results and Business Highlights

    Nov 12 12:18 ET

  • Acumen Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 13 16:47 ET

  • Acumen Pharmaceuticals | 8-K: Acumen Pharmaceuticals Reports Second Quarter 2024 Financial Results and Business Highlights

    Aug 13 07:52 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 22, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data